| Particulars (Rupees in Crores.) | Mar-2025 | Sept-2024 | Mar-2024 | Sept-2023 | Mar-2023 | 
|---|---|---|---|---|---|
| Gross Sales | 1,233.36 | 1,153.67 | 1,225.94 | 1,302.64 | 1,406.37 | 
| Excise Duty | 0 | 0 | 0 | 0 | 0 | 
| Net Sales | 1,233.36 | 1,153.67 | 1,225.94 | 1,302.64 | 1,406.37 | 
| Other Operating Income | 0 | 0 | 0 | 0 | 0 | 
| Other Income | 13.77 | 2.59 | 2.74 | 1.29 | 1.88 | 
| Total Income | 1,247.13 | 1,156.26 | 1,228.68 | 1,303.93 | 1,408.25 | 
| Total Expenditure | 1,078.3 | 1,021.66 | 1,069.99 | 1,142.13 | 1,242.18 | 
| PBIDT | 168.83 | 134.6 | 158.69 | 161.8 | 166.07 | 
| Interest | 18.23 | 17.64 | 16.73 | 16.79 | 18 | 
| PBDT | 150.6 | 116.96 | 141.96 | 145.01 | 148.07 | 
| Depreciation | 28.68 | 27.1 | 26.24 | 25.21 | 25.12 | 
| Minority Interest Before NP | 0 | 0 | 0 | 0 | 0 | 
| Tax | 22.37 | 18.81 | 29.37 | 30.19 | 32.96 | 
| Deferred Tax | -0.32 | 2.82 | 2.33 | 2.04 | -2.86 | 
| Reported Profit After Tax | 99.87 | 68.23 | 84.02 | 87.57 | 92.85 | 
| Minority Interest After NP | -0.04 | -0.02 | 0.04 | 0.13 | 0.08 | 
| Net Profit after Minority Interest | 99.91 | 68.25 | 83.98 | 87.44 | 92.77 | 
| Extra-ordinary Items | 0 | 0 | 0 | 0 | 0 | 
| Adjusted Profit After Extra-ordinary item | 99.91 | 68.25 | 83.98 | 87.44 | 92.77 | 
| EPS (Unit Curr.) | 10.95 | 7.48 | 9.13 | 9.47 | 10.02 | 
| Book Value (Unit Curr.) | 0 | 0 | 0 | 0 | 0 | 
| Dividend (%) | 0 | 0 | 0 | 0 | 0 | 
| Equity | 91.27 | 91.27 | 91.94 | 91.94 | 92.6 | 
| Public Shareholding (Number) | 0 | 0 | 0 | 0 | 0 | 
| Public Shareholding (%) | 0 | 0 | 0 | 0 | 0 | 
| Pledged/Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 | 
| Pledged/Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 | 
| Pledged/Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 | 
| Non Encumbered - No. of Shares | 0 | 0 | 0 | 0 | 0 | 
| Non Encumbered - % in Total Promoters Holding | 0 | 0 | 0 | 0 | 0 | 
| Non Encumbered - % in Total Equity | 0 | 0 | 0 | 0 | 0 | 
| PBIDTM(%) | 13.68 | 11.66 | 12.94 | 12.42 | 11.8 | 
| PBDTM(%) | - | - | - | - | - | 
| PATM(%) | 8.09 | 5.91 | 6.85 | 6.72 | 6.6 | 
The consolidated net profit of the company increased 1.1% YoY at ₹37.1 crore from ₹36.7 crore that was reported for the same quarter last year.
Aarti Drugs shares has witnessed a 8% dip in the last one year, and 10% dip in the last six months.
Here are some of the stocks that may see significant price movement today: Avenue Supermarts, Bank of Baroda, HDFC Bank, etc.
Here are some of the stocks that may see significant price movement today: HFCL, Aster DM Healthcare, Tata Steel, Glenmark Pharma, etc.








 IIFL Customer Care Number
 IIFL Customer Care Number 
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000  / 7039-050-000
 IIFL Capital Services Support WhatsApp Number
 IIFL Capital Services Support WhatsApp Number
+91 9892691696


IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.